Mucoadhesion and the gastrointestinal tract.
The concept of mucoadhesion is one that has the potential to improve the highly variable residence times experienced by drugs and dosage forms at various sites in the gastrointestinal tract, and consequently, to reduce variability and improve efficacy. Intimate contact with the mucosa should enhance absorption or improve topical therapy. A variety of approaches have been investigated for mucoadhesion in the gastrointestinal tract, particularly for the stomach and small intestine. Despite interesting results in these sites, mucoadhesive approaches have not yet shown success in humans. The potential of the lower gut for these applications has been largely neglected, although the large intestine in particular may benefit, and the colon has several factors that suggest mucoadhesion could be successful there, including lower motility and the possibility of a lower mucus turnover and thicker mucus layer. In vitro studies on colonic mucoadhesion show promise, and rectal administration has shown some positive results in vivo. This review considers the background to mucoadhesion with respect to the physiological conditions of the gastrointestinal tract as well as the principles that underlie this concept. Mucoadhesive approaches to gastrointestinal drug delivery will be examined, with particular attention given to the lower gut.
Laboratory of Pharmaceutical Technology, Faculty of Pharmacy, University of Coimbra, Coimbra 3000-295, Portugal.
Felipe J O
FJ
Varum
Emma L
EL
McConnell
Joao J S
JJ
Sousa
Francisco
F
Veiga
Abdul W
AW
Basit
D000268:Adhesiveness; D000284:Administration, Oral; D000818:Animals; D016503:Drug Delivery Systems; D041981:Gastrointestinal Tract / Q000378:metabolism*; D005772:Gastrointestinal Transit; D006801:Humans; D009092:Mucous Membrane / Q000378:metabolism; D004364:Pharmaceutical Preparations / Q000008:administration & dosage / Q000378:metabolism*; D010599:Pharmacokinetics
D004364:Pharmaceutical Preparations